the effectiveness of intramuscular 15-methyl-prostaglandin f2alpha ( 15-methyl-pgf2alpha ) application for therapeutic abortion was studied in 16 women during the first and second trimester ( 12 to 17 weeks ) of pregnancy .
C0007047
15-methyl-prostaglandin f2alpha
C0032961
pregnancy